# Regis Corp: Form 10-Q for the period ended Dec 31, 2025

- Company: [Regis Corp](/companies/rgs.md) (CIK 716643)
- Form: 10-Q
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 06:08 ET
- Period: 2025-12-31
- Accession: 0000716643-26-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/716643/000071664326000006/rgs-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/716643/000071664326000006/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-10-01 to 2025-12-31 | $57.1m | us-gaap:Revenues |
| Revenue | 6 months, 2025-07-01 to 2025-12-31 | $116.1m | us-gaap:Revenues |
| Operating income | 3 months, 2025-10-01 to 2025-12-31 | $6.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2025-07-01 to 2025-12-31 | $12.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-10-01 to 2025-12-31 | $5.3m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2025-07-01 to 2025-12-31 | $10.5m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2025-10-01 to 2025-12-31 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2025-07-01 to 2025-12-31 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-10-01 to 2025-12-31 | $456.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2025-07-01 to 2025-12-31 | $1.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-10-01 to 2025-12-31 | $0.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2025-07-01 to 2025-12-31 | $0.64 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-10-01 to 2025-12-31 | $0.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2025-07-01 to 2025-12-31 | $0.74 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-10-01 to 2025-12-31 | 2,862,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2025-07-01 to 2025-12-31 | 2,822,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2025-07-01 to 2025-12-31 | $3.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2025-07-01 to 2025-12-31 | $1.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2025-12-31 | $18.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $52.1m | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $588.3m | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $98.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $399.6m | us-gaap:Liabilities |
| Long-term debt | at 2025-12-31 | $111.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-12-31 | $2.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2025-12-31 | $188.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/716643/000071664326000006/rgs-20251231.htm

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0000716643-26-000006. Last ingested by Listed: Oct 30, 2026, 18:10 ET. No prices; not investment advice.